Decsontructing The Latest The Medicines Company (MDCO) Release
The Medicines Company (NASDAQ:MDCO) just put out topline from its lead cholesterol trial, and the company has jumped on the back of the data.
Author Archive - Market Exclusive
Should You Worry About What TG Therapeutics Inc (NASDAQ:TGTX) Has Just Done?
TG Therapeutics Inc (NASDAQ:TGTX) has unexpectedly altered the protocol for the GENUINE Phase 3 clinical trial of its lead drug candidate TG-1101.
GlaxoSmithKline Plc (GSK) Shrugs Skeptics Concerns To Launch Cold Flu Tracker App
GlaxoSmithKline Plc (NYSE:GSK) is forging forward with its cold and flu tracker app even on coming under criticism from skeptics who continue to question the motive behind its...
Is Teva Pharmaceutical Industries Ltd (TEVA) Planning Celltrion Takeover To Bolster Biosimilar Portfolio?
Reports in the pharmaceutical space indicate that Teva Pharmaceutical Industries Ltd (NYSE:TEVA) might be planning to acquire South Korea biosimilar giant Celltrion.
Intersect ENT Inc (XENT) Is An Opportunity To Get In On An Under Reaction
Yesterday, Intersect ENT Inc (NASDAQ:XENT) announced that a phase III pivotal trial for its lead candidate met its endpoints, and that the company is set to put forward an authorization...
Here’s What You Need to Know about ContraVir Pharmaceuticals Inc (CTRV)
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) soared into the close of last week on the back of a data release from its lead hepatitis B trial, and t looks as though this week is...
Is Egalet Corp (EGLT) A Discount Entry On Its FDA Delay?
One thing we love to do here at Market Exclusive is to highlight potential discount entries in the biotech space.
BlackBerry Ltd (BBRY) Takes Down DTEK60 Preorder Page
The DTEK60 handset was made available for preorder earlier this week but the company has since then removed the preorder page.
AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas
AstraZeneca Plc (ADR) (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization agreement with a subsidiary...
Why 3D Systems Corporation (DDD), Stratasys, Ltd. (SSYS) Are No Longer At Ease
3D Systems Corporation (NYSE:DDD) and Stratasys, Ltd.
Here’s What We Want To See From Adaptimmune Therapeutics PLC – ADR (ADAP)
Earlier in August, we highlighted Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP) as being a company to watch going forward, with a specific focus on the company’s pipeline...
Otonomy Inc (OTIC) Stock: Pivotal Data In Focus
Otonomy Inc (NASDAQ:OTIC) is set to put out data from a phase III in its lead asset, Otiprio, before the year draws to a close.
Biotech Movers And Shakers: Vericel Corp (VCEL) and Illumina, Inc. (ILMN)
Yet again we’ve had a busy day in the biotech space, with a number of companies gaining and declining on the back of positive or negative data.
Here’s Our Take On Neurocrine Biosciences, Inc. (NBIX)’s Ingrezza
Neurocrine Biosciences, Inc.
What’s The Deal Between MetaStat Inc. (MTST) And Celgene Corporation (CELG)?
It was back in April when the Chief Medical Officer of pharma giant Celgene Corporation (NASDAQ:CELG), Dr. Jerome B. Zeldis joined the board of MetaStat Inc. (OTCMKTS:MTST).
Here’s Our RedHill Biopharma Ltd – ADR (RDHL) Yeliva Phase II Preview
RedHill Biopharma Ltd – ADR (NASDAQ:RDHL) just announced the initiation of the latest element of its Yeliva development program, and the company has teed up for a number of ...
Here’s What Happened With Alnylam Pharmaceuticals, Inc. (ALNY) and Tenax Therapeutics Inc (TENX)
A couple of companies have had a tough twenty-four hours in the biotech space.
Teva Pharmaceutical Industries Ltd. (TEVA), Celltrion, Team Up To Market mAb Biosimilars
Teva Pharmaceutical Industries Ltd.
Arrowhead Pharmaceuticals Inc. (ARWR), Spring Bank Pharmaceuticals, Inc. (SBPH) Collaborate On HBV
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) and Spring Bank Pharmaceuticals, Inc.
Novartis AG (NVS) Relocates NITD To California
James Bradner, Novartis AG (NYSE:NVS) Novartis Institutes for BioMedical Research President, has recently confirmed that the company will move the Novartis Institute for Tropical...
Merck & Co. Inc. (MRK) Shuts Down Florida Facility
The pharmaceutical giant intends to lay off employees in two waves, the first of which is set next month and the other one in December.
Three Cancer Plays For The Fourth Quarter Of 2016
We are now into the final quarter of 2016, and there looks set to be plenty of activity across the biotech space before the year draws to a close.
Two Biotech Companies That Have Taken A Hit In The Past Week
A number of companies have taken severe hits over the last week in the small cap biotech space, but a handful of these have had a particularly bad start to the final quarter of...
Here Are Two Dates To Watch In Biotech This October
It’s going to be a busy month in the biotech space. Here are two companies to keep an eye on, and why this month could be big for both.
Here’s Why Biodel Inc (BIOD) Just Gained, And What It Means
A small cap biotech named Biodel Inc (NASDAQ:BIOD) based out of Connecticut just logged close to 20% gains yesterday.
What Are Egalet Corp (EGLT)’s Chances Come PDUFA?
Egalet Corp (NASDAQ:EGLT) had a pretty tough first couple of quarters, but the third quarter of 2016 was good to the company as sentiment shifted ahead of a major potential catalyst...
Inside The FDA: Spectrum Pharmaceuticals, Inc. (SPPI) and its Bladder Cancer Treatment, Apaziquone
On September 14, 2016, the FDA’s Oncologic Drugs Advisory Committee met to evaluate and discuss a drug called apaziquone.
Here’s A Look At AC Immune Ltd (ACIU)’s Alzheimer’s Candidate, Crenezumab
AC Immune Ltd (NASDAQ:ACIU) just hit markets with what turned out to be a relatively weak initial public offering.
Here’s Why We’re Excited About The Upcoming Minerva Neurosciences Inc (NERV) Data
Minerva Neurosciences Inc (NASDAQ:NERV) just served up an update as to the progress of its two lead programs, and the company has remained relatively flat on the insight.
Does Novartis AG (NVS) Have The Solution For Malaria?
Results for a potentially game-changing proof of concept study were just published concerning malaria by Novartis AG (NYSE:NVS) in the New England Journal of Medicine.
Johnson & Johnson (JNJ)’s Janssen Builds On Partnership With Geron Corporation (GERN)
Janssen Pharmaceuticals, a subsidiary of the giant manufacturing company, Johnson & Johnson (NYSE:JNJ) has expanded the current partnership with the long-beleaguered Geron Corporation...
Medecins Sans Frontieres Happy with GlaxoSmithKline PLC (ADR) (GSK) Price Reduction For Synflorix
Numerous complaints by medical charity Medecins Sans Frontieres over the cost of pneumococcal vaccine given to refugees by GlaxoSmithKline PLC (ADR) (NYSE:GSK) have yielded fruit...
Romosozumab From Amgen Inc (AMGN) Shows Positive Results In Osteoporosis
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval from the FDA until ...
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Completes Cystic Fibrosis Enrollment as Stock Explodes Higher
Something is happening with Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP). Since February, the stock has risen 600%, 158% since August alone.
Pluristem Therapeutics Inc. (PSTI) Gears Up For Critical Blood Stem Cell Trial
Investors who play the developing biotech niche are always on the lookout for shortcuts to approval. A shortcut can come in two ways.
Inside the FDA: Why The Pfizer, Inc. (PFE) Boxed Warning On Chantix Is Unlikely To Be Removed
On September 14, the Food and Drug Administration released two briefing documents for the joint meeting of two committees.
Two Biotechs With Bad News This Week: What Happens Now?
When things go well in biotech, it can be a great ride.
Why The Mast Therapeutics Inc (MSTX) Dip Might Be An Opportunity
Mast Therapeutics Inc (NYSEMKT:MSTX) lost nearly 25% of its market capitalization on Tuesday, as the company failed to serve up an expected presentation at the Rodman & Renshaw...
Barrick Gold Corporation (USA) (ABX) Taps Cisco Systems, Inc. (CSCO) To Help Modernize Operations
Barrick Gold Corporation (USA) (NYSE:ABX), billed as the world’s leading gold producer, is up to something big: digitizing company-wide operations.
Looking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data
TESARO Inc (NASDAQ:TSRO) just announced that the FDA has granted Fast Track designation to its lead ovarian, fallopian tube, or primary peritoneal cancer candidate, and that on...
Delving Into The Lexicon Pharmaceuticals, Inc. (LXRX) Data
Lexicon Pharmaceuticals, Inc.
Biotech Movers: Lantheus Holdings Inc (LNTH) and Achillion Pharmaceuticals, Inc. (ACHN)
As we noted last week, the close of the third quarter and the start of the final quarter of the year is when volume really starts to pick up in wider financial asset markets, ...
Inside The FDA: Eli Lilly and Co (LLY) Jardiance Aims at Proving Cardiovascular Benefit in Diabetes, Will FDA Agree?
On June 28, 2016, the Endocrinologic and Metabolic Drugs Advisory Committee of the Food and Drug Administration (FDA) met to discuss and vote upon a supplemental New Drug Application...
Here’s What Latest Data Could Mean For Repros Therapeutics Inc (RPRX)
Repros Therapeutics Inc (NASDAQ:RPRX) just put out data from its phase II in moderate to severe endometriosis, and the company has gained close to 17% on the data.
Biotech Movers: Retrophin Inc (RTRX) and Agios Pharmaceuticals Inc (AGIO)
Summer is officially over, and the warm weather volume lull is has come to an end.
This Buy/Write Could Be Your Next PLAY | Dave & Buster’s Entertainment, Inc. (PLAY)
Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) shares are off this morning after posting disappointing same-store sales in yesterday’s earnings report.
BioMarin Pharmaceutical Inc. (BMRN)’s Setback Isn’t Really A Setback
BioMarin Pharmaceutical Inc.
CoLucid Pharmaceuticals Inc (CLCD): What The Data Means
Towards the end of August, we published this piece detailing two major potential upside catalysts to keep an eye on early September.
